Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 51: 177-182, 2005. First published October 28, 2004; 10.1373/clinchem.2004.038679
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
clinchem.2004.038679v1
51/1/177    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bristow, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bristow, A.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Evidence Based Laboratory Medicine and Test Utilization
Right arrow Proteomics and Protein Markers
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2005;51:177-182.)
© 2005 American Association for Clinical Chemistry, Inc.


Endocrinology and Metabolism

Establishment, Value Assignment, and Characterization of New WHO Reference Reagents for Six Molecular Forms of Human Chorionic Gonadotropin

Adrian Bristow1, Peter Berger2, Jean-Michel Bidart3, Steven Birken4, Robert Norman5, Ulf-Håkan Stenman6 and Catharine Sturgeon7,a on behalf of the IFCC Working Group on hCG

1 National Institute for Biological Standards and Control, Potters Bar, Herts, United Kingdom.
2 Institute for Biomedical Aging Research, Austrian Academy of Sciences, Innsbruck, Austria.
3 Department of Clinical Biology, Institut Gustave-Roussy, Villejuif, France.
4 Department of Obstetrics and Gynecology, College of Physicians and Surgeons of Columbia University, New York, NY.
5 Research Centre for Reproductive Health, Department of Obstetrics and Gynaecology, University of Adelaide, The Queen Elizabeth Hospital, Woodville, Australia.
6 Department of Clinical Chemistry, Helsinki University Central Hospital, Finland.
7 Department of Clinical Biochemistry, Royal Infirmary, Edinburgh, United Kingdom.

aAddress correspondence to this author at: Department of Clinical Biochemistry, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, United Kingdom. Fax 44-131-242-6882; e-mail C.Sturgeon{at}ed.ac.uk.

Background: The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) established a Working Group to investigate means of improving the comparability of immunoassays for human chorionic gonadotropin (hCG), which was selected as a prototype glycoprotein analyte. The Working Group identified development of unambiguous nomenclature and production of new highly purified International Reference Reagents calibrated in substance concentrations as its primary objectives.

Methods: Preparations of intact hCG, nicked hCG, hCG ß-subunit, nicked hCG ß-subunit, hCG {alpha}-subunit, and hCG ß-core fragment were purified from a crude urinary hCG preparation, ampouled, lyophilized, and assigned values in substance concentrations (mol/L). Value assignment and accelerated degradation studies were carried out in accordance with WHO protocols for International Reference Reagents.

Results: The ampouled standards were assigned final values based on the recovery of immunoreactive material after reconstitution. The degradation studies showed that the standards were highly stable.

Conclusions: The nomenclature of hCG-related molecules and immunoassays has been adopted by the IFCC, and the standards prepared and characterized by the Working Group have been formally adopted by the WHO as the First International Reference Reagents for six hCG-related molecules. These developments will enable better understanding of what assays for hCG measure and should ultimately help to improve the clinical application of these assays.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
S. E. Manley, I. M. Stratton, P. M. Clark, and S. D. Luzio
Comparison of 11 Human Insulin Assays: Implications for Clinical Investigation and Research
Clin. Chem., May 1, 2007; 53(5): 922 - 932.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
U.-H. Stenman, A. Tiitinen, H. Alfthan, and L. Valmu
The classification, functions and clinical use of different isoforms of HCG
Hum. Reprod. Update, November 1, 2006; 12(6): 769 - 784.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Association for Clinical Chemistry.